InsidersTradesSigma
Follow the Alliqua BioMedical, Inc. share price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.3bn. The latest transaction was reported on 11 February 2016 (Attribution). Among the most active insiders: BARTON BRADFORD. Every trade is accessible without an account.
Analysts rate Alliqua BioMedical, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
Alliqua BioMedical, Inc. 是一家专注于开发医疗保健产品的公司，特别是在生物材料和先进疗法领域。该公司在 XNAS 市场上市。